Crinetics Pharmaceuticals reported a gross margin of 99.39% and a net margin of -479.46% for the quarter ended Jun 2026. These financial ratios cover 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||
| Gross Margin | 100.00% | 100.00% | 98.14% | 99.39% | |||||||||||||||||||||||||||||||||
| EBT Margin | -17,113.91% | 1,073.68% | 9,652.62% | 9,153.93% | 6,345.70% | 1,716.87% | 5,159.82% | 16,318.21% | 10,384.38% | 18,560.15% | 26,807.20% | 11,216.00% | -90,972.73% | -1,990.50% | -1,189.81% | -479.46% | |||||||||||||||||||||
| EBIT Margin | -2,865.31% | -1,080.39% | -9,805.24% | -9,487.77% | -6,707.48% | -1,790.89% | -5,363.87% | -17,045.38% | -11,488.91% | -20,747.62% | -30,860.11% | -12,522.99% | -99,710.49% | -2,169.55% | -1,307.79% | -527.35% | |||||||||||||||||||||
| EBITDA Margin | -2,865.31% | -1,080.39% | -9,805.24% | -9,487.77% | -6,707.48% | -1,790.89% | -5,363.87% | -17,045.38% | -11,488.91% | -20,747.62% | -30,860.11% | -12,522.99% | -99,710.49% | -2,169.55% | -1,307.79% | -527.35% | |||||||||||||||||||||
| Operating Margin | -2,865.31% | -1,080.39% | -9,805.24% | -9,487.77% | -6,707.48% | -1,790.89% | -5,363.87% | -17,045.38% | -11,488.91% | -20,747.62% | -30,860.11% | -12,522.99% | -99,710.49% | -2,169.55% | -1,307.79% | -527.35% | |||||||||||||||||||||
| Net Margin | -17,113.91% | 1,073.68% | 9,652.62% | 9,153.93% | 6,345.70% | 1,716.87% | 5,159.82% | 16,318.21% | 10,384.38% | 18,560.15% | 26,807.20% | 11,216.00% | -90,972.73% | -1,990.50% | -1,189.81% | -479.46% | |||||||||||||||||||||
| FCF Margin | -2,125.88% | -435.32% | -6,512.30% | -8,550.44% | -5,004.37% | -1,521.13% | -4,651.32% | -12,959.25% | -8,466.88% | -12,180.20% | -24,845.15% | -8,637.54% | -78,028.67% | -1,515.32% | -1,169.40% | -377.08% | |||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 2.54M | 3.28M | |||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 213.14M | 280.19M | 342.15M | 377.51M | 403.31M | 368.53M | 333.09M | 303.63M | 467.40M | 638.45M | 806.75M | 956.84M | 936.45M | 1,185.98M | 1,397.96M | 1,325.45M | 1,242.80M | 1,161.14M | 1,263.79M | 1,361.60M | |||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | ||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | |||||||||||||||||||||||||||||||||||||
| Times Interest Earned | |||||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | 29.19 | -5.92 | 31.21 | 23.64 | 25.20 | 21.91 | 18.85 | 19.33 | 35.14 | -6.69 | 55.32 | 47.98 | -53.77 | -58.95 | 32.41 | 23.41 | -30.27 | -36.28 | -29.95 | -32.88 | |||||||||||||||||
| Price to SalesP/S | 0.00M | 335.11 | 0.00M | 0.00M | 0.00M | 323.66 | 997.34 | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.03M | 722.13 | 356.34 | 157.63 | |||||||||||||||||||||
| Price to BookP/B | 4.20 | 3.29 | 3.46 | 2.59 | 3.01 | 3.12 | 3.09 | 3.88 | 3.62 | 4.50 | 4.20 | 4.28 | 4.96 | 3.59 | 2.50 | 2.31 | 3.67 | 4.48 | 2.99 | 3.32 | |||||||||||||||||
| Enterprise Value | 619.63M | 757.76M | 729.51M | 593.37M | 688.19M | 650.22M | 570.96M | 720.84M | 1,429.24M | 1,867.11M | 2,775.45M | 2,689.88M | 3,268.31M | 3,397.24M | 1,862.70M | 1,510.70M | 2,845.63M | 3,421.13M | 2,533.70M | 2,753.56M | |||||||||||||||||
| EV to EBIT | -22.28 | -24.53 | -21.57 | -13.78 | -15.84 | -13.67 | -11.90 | -13.60 | -24.23 | -29.80 | -37.75 | -32.49 | -37.23 | -35.86 | -16.72 | -11.70 | -19.96 | -25.59 | -18.05 | -20.79 | |||||||||||||||||
| EV to EBITDA | -22.28 | -24.53 | -21.57 | -13.78 | -15.84 | -13.67 | -11.90 | -13.60 | -24.23 | -29.80 | -37.75 | -32.49 | -37.23 | -35.86 | -16.72 | -11.70 | -19.96 | -25.59 | -18.05 | -20.79 | |||||||||||||||||
| Market Capitalization | 812.95M | 1,091.97M | 1,049.23M | 1,001.88M | 1,056.55M | 985.95M | 867.08M | 985.37M | 1,983.90M | 2,425.67M | 3,676.41M | 3,552.83M | 4,130.97M | 4,751.31M | 3,136.83M | 2,707.06M | 3,937.92M | 4,449.02M | 3,825.00M | 3,959.34M | |||||||||||||||||
| Price to FCFP/FCF | -31.49 | -47.65 | -76.98 | -35.04 | -26.98 | -27.79 | -21.28 | -21.44 | -44.24 | -58.11 | -67.85 | -73.11 | -65.21 | -69.98 | -34.97 | -30.40 | -35.29 | -47.65 | -30.47 | -41.80 | |||||||||||||||||
| EV to FCF | -24.00 | -33.07 | -53.52 | -20.76 | -17.57 | -18.33 | -14.01 | -15.69 | -31.87 | -44.73 | -51.22 | -55.35 | -51.59 | -50.03 | -20.77 | -16.96 | -25.50 | -36.64 | -20.19 | -29.07 | |||||||||||||||||
| EV to CFO | -24.14 | -33.09 | -53.87 | -21.21 | -17.88 | -18.47 | -14.02 | -15.76 | -34.57 | -45.76 | -52.51 | -56.46 | -52.02 | -50.80 | -21.06 | -17.60 | -25.70 | -36.83 | -20.32 | -29.23 | |||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -2,865.31% | -1,080.39% | -9,805.24% | -9,487.77% | -6,707.48% | -1,790.89% | -5,363.87% | -17,045.38% | -5,547.17% | -11,488.91% | -20,747.62% | -29,525.22% | -32,613.47% | -30,860.11% | -12,522.99% | -99,710.49% | -2,169.55% | -1,307.79% | -527.35% | ||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -49.13% | -40.77% | -36.85% | -38.58% | -39.92% | -49.26% | -59.34% | -70.84% | -48.60% | -37.44% | -32.87% | -30.80% | -34.75% | -30.09% | -28.10% | -33.65% | -40.89% | -48.02% | -45.76% | -42.84% | |||||||||||||||||
| Return on Assets [ROA]ROA | 25.86% | -38.42% | -28.33% | -21.36% | -16.51% | 44.21% | 52.62% | 60.56% | 42.45% | -32.79% | -23.41% | -17.33% | -31.94% | -1.43% | 0.96% | 4.15% | 0.14% | -3.47% | -20.95% | -36.79% |